Chapter 9 292 Schoretsanitis, G., Deligiannidis, K. M., Paulzen, M., Spina, E., & de Leon, J. (2022). Drug-drug interactions between psychotropic medications and oral contraceptives. Expert Opinion on Drug Metabolism & Toxicology, 18(6), 395-411. https://doi.org/10.1080/17425255.2022. 2106214 Schoretsanitis, G., Kane, J. M., & de Leon, J. (2020). Adding Oral Contraceptives to Clozapine May Require Halving the Clozapine Dose: A New Case and a Literature Review. Journal of Clinical Psychopharmacology, 40(3), 308. https://doi.org/10.1097/JCP.0000000000001202 Schuh, K. M., Ahmed, J., Kwak, E., Xu, C. X., Davis, T. T., Aronoff, C. B., & Tronson, N. C. (2024). A mouse model of oral contraceptive exposure: Depression, motivation, and the stress response. Hormones and Behavior, 158, 105470. https://doi.org/10.1016/j.yhbeh.2023. 105470 Schweizer-Schubert, S., Gordon, J. L., Eisenlohr-Moul, T. A., Meltzer-Brody, S., Schmalenberger, K. M., Slopien, R., Zietlow, A.-L., Ehlert, U., & Ditzen, B. (2021). Steroid Hormone Sensitivity in Reproductive Mood Disorders: On the Role of the GABAA Receptor Complex and Stress During Hormonal Transitions. Frontiers in Medicine, 7. https://www.frontiersin.org/articles/ 10.3389/fmed.2020.479646 Scott, R. T. J., Ross, B., Anderson, C., & Archer, D. F. (1991). Pharmacokinetics of Percutaneous Estradiol: A Crossover Study Using a Gel and a Transdermal System in Comparison With Oral Micronized Estradiol. Obstetrics & Gynecology, 77(5), 758. Shorey, S., Chee, C. Y. I., Ng, E. D., Chan, Y. H., Tam, W. W. S., & Chong, Y. S. (2018). Prevalence and incidence of postpartum depression among healthy mothers: A systematic review and meta-analysis. Journal of Psychiatric Research, 104, 235-248. https://doi.org/10.1016/ j.jpsychires.2018.08.001 Silveyra, P., Cataldi, N. I., Lux-Lantos, V., & Libertun, C. (2009). Gonadal steroids modulated hypocretin/orexin type-1 receptor expression in a brain region, sex and daytime specific manner. Regulatory Peptides, 158(1), 121-126. https://doi.org/10.1016/j.regpep.2009.08.002 Slabbekoorn, D., Van Goozen, S. H. M., Gooren, L. J. G., & Cohen-Kettenis, P. T. (2001). Effects of cross-sex hormone treatment on emotionality in transsexuals. International Journal of Transgenderism, 5, No Pagination Specified-No Pagination Specified. Soares, C. N., & Zitek, B. (2008). Reproductive hormone sensitivity and risk for depression across the female life cycle: A continuum of vulnerability? Journal of Psychiatry and Neuroscience, 33(4), 331-343. Steinberg, E. M., Cardoso, G. M. P., Martinez, P. E., Rubinow, D. R., & Schmidt, P. J. (2012). Rapid Response to Fluoxetine in Women with Premenstrual Dysphoric Disorder. Depression and Anxiety, 29(6), 531-540. https://doi.org/10.1002/da.21959 Sumner, B. E. H., & Fink, G. (1995). Estrogen increases the density of 5-Hydroxytryptamine2A receptors in cerebral cortex and nucleus accumbens in the female rat. The Journal of Steroid Biochemistry and Molecular Biology, 54(1), 15-20. https://doi.org/10.1016/09600760(95)00075-B Swales, D. A., Lozza-Fiacco, S., Andersen, E. H., Cooper, J. A., Treadway, M. T., Xia, K., Schiller, C. E., Girdler, S. S., & Dichter, G. S. (2023). Hormone sensitivity predicts the beneficial effects of transdermal estradiol on reward-seeking behaviors in perimenopausal women: A randomized controlled trial. Psychoneuroendocrinology, 156, 106339. https://doi.org/ 10.1016/j.psyneuen.2023.106339 Talib, H. J., & Alderman, E. M. (2013). Gynecologic and Reproductive Health Concerns of Adolescents Using Selected Psychotropic Medications. Journal of Pediatric and Adolescent Gynecology, 26(1), 7-15. https://doi.org/10.1016/j.jpag.2012.05.011 Tharpe, N. (2011). Adverse Drug Reactions in Women’s Health Care. Journal of Midwifery & Women’s Health, 56(3), 205-213. https://doi.org/10.1111/j.1542-2011.2010.00050.x Toufexis, D., Rivarola, M. A., Lara, H., & Viau, V. (2014). Stress and the Reproductive Axis. Journal of Neuroendocrinology, 26(9), 573-586. https://doi.org/10.1111/jne.12179
RkJQdWJsaXNoZXIy MTk4NDMw